Advertisement

Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women

Published:September 20, 2022DOI:https://doi.org/10.1016/j.amepre.2022.08.004

      Introduction

      In 2009, the U.S. Preventive Services Task Force updated recommended mammography screening frequency from annual to biennial for average-risk women aged 50–74 years. The association between estimated breast cancer risk and mammography screening frequency was evaluated.

      Methods

      A single-center retrospective cohort study was conducted among racially/ethnically diverse women, aged 50–74 years, who underwent screening mammography from 2014 to 2018. Data on age, race/ethnicity, first-degree family history of breast cancer, previous benign breast biopsies, and mammographic density were extracted from the electronic health record to calculate Breast Cancer Surveillance Consortium 5-year risk of invasive breast cancer, with a 5-year risk ≥1.67% defined as high risk. Multivariable analyses were conducted to determine the association between breast cancer risk factors and mammography screening frequency (annual versus biennial). Data were analyzed from 2020 to 2022.

      Results

      Among 12,929 women with a mean age of 61±6.9 years, 82.7% underwent annual screening mammography, and 30.7% met high-risk criteria for breast cancer. Hispanic women were more likely to screen annually than non-Hispanic Whites (85.0% vs 79.8%, respectively), despite fewer meeting high-risk criteria. In multivariable analyses adjusting for breast cancer risk factors, high- versus low/average-risk women (OR=1.17; 95% CI=1.04, 1.32) and Hispanic versus non-Hispanic White women (OR=1.46; 95% CI=1.29, 1.65) were more likely to undergo annual mammography.

      Conclusions

      A majority of women continue to undergo annual screening mammography despite only a minority meeting high-risk criteria, and Hispanic women were more likely to screen annually despite lower overall breast cancer risk. Future studies should focus on the implementation of risk-stratified breast cancer screening strategies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

      1. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review.
        Lancet. 2012; 380: 1778-1786https://doi.org/10.1016/S0140-6736(12)61611-0
        • Nelson HD
        • Tyne K
        • Naik A
        • et al.
        Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2009; 151: 727-737https://doi.org/10.7326/0003-4819-151-10-200911170-00009
        • Nelson HD
        • Fu R
        • Cantor A
        • Pappas M
        • Daeges M
        • Humphrey L.
        Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation.
        Ann Intern Med. 2016; 164: 244-255https://doi.org/10.7326/M15-0969
        • Myers ER
        • Moorman P
        • Gierisch JM
        • et al.
        Benefits and harms of breast cancer screening: a systematic review.
        JAMA. 2015; 314: 1615-1634https://doi.org/10.1001/jama.2015.13183
        • Siu AL
        U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2016; 164: 279-296https://doi.org/10.7326/M15-2886
        • Oeffinger KC
        • Fontham ET
        • Etzioni R
        • et al.
        Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.
        JAMA. 2015; 314: 1599-1614https://doi.org/10.1001/jama.2015.12783
        • Bevers TB
        • Anderson BO
        • Bonaccio E
        • et al.
        NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.
        J Natl Compr Canc Netw. 2009; 7: 1060-1096https://doi.org/10.6004/jnccn.2009.0070
        • Wilt TJ
        • Harris RP
        • Qaseem A
        High Value Care Task Force of the American College of Physicians. Screening for cancer: advice for high-value care from the American College of Physicians.
        Ann Intern Med. 2015; 162: 718-725https://doi.org/10.7326/M14-2326
      2. Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women.
        Obstet Gynecol. 2017; 130: e1-e16https://doi.org/10.1097/AOG.0000000000002158
        • Lee CH
        • Dershaw DD
        • Kopans D
        • et al.
        Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
        J Am Coll Radiol. 2010; 7: 18-27https://doi.org/10.1016/j.jacr.2009.09.022
        • Nelson HD
        • Pappas M
        • Cantor A
        • Griffin J
        • Daeges M
        • Humphrey L.
        Harms of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force recommendation.
        Ann Intern Med. 2016; 164: 256-267https://doi.org/10.7326/M15-0970
        • Christiansen CL
        • Wang F
        • Barton MB
        • et al.
        Predicting the cumulative risk of false-positive mammograms.
        J Natl Cancer Inst. 2000; 92: 1657-1666https://doi.org/10.1093/jnci/92.20.1657
        • Elmore JG
        • Barton MB
        • Moceri VM
        • Polk S
        • Arena PJ
        • Fletcher SW.
        Ten-year risk of false positive screening mammograms and clinical breast examinations.
        N Engl J Med. 1998; 338: 1089-1096https://doi.org/10.1056/NEJM199804163381601
      3. Ong MS, Mandl KD. National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year. Health Aff (Millwood). 2015;34(4):576–583. https://doi.org/10.1377/hlthaff.2014.1087.

        • Hubbard RA
        • Kerlikowske K
        • Flowers CI
        • Yankaskas BC
        • Zhu W
        • Miglioretti DL.
        Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
        Ann Intern Med. 2011; 155: 481-492https://doi.org/10.7326/0003-4819-155-8-201110180-00004
        • Harding C
        • Pompei F
        • Burmistrov D
        • Welch HG
        • Abebe R
        • Wilson R.
        Breast cancer screening, incidence, and mortality across U.S. counties.
        JAMA Intern Med. 2015; 175: 1483-1489https://doi.org/10.1001/jamainternmed.2015.3043
        • Mandelblatt JS
        • Stout NK
        • Schechter CB
        • et al.
        Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies.
        Ann Intern Med. 2016; 164: 215-225https://doi.org/10.7326/M15-1536
        • Braithwaite D
        • Zhu W
        • Hubbard RA
        • et al.
        Screening outcomes in older us women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?.
        J Natl Cancer Inst. 2013; 105: 334-341https://doi.org/10.1093/jnci/djs645
        • Wernli KJ
        • Arao RF
        • Hubbard RA
        • et al.
        Change in breast cancer screening intervals since the 2009 USPSTF guideline.
        J Womens Health (Larchmt). 2017; 26: 820-827https://doi.org/10.1089/jwh.2016.6076
        • Pace LE
        • He Y
        • Keating NL.
        Trends in mammography screening rates after publication of the 2009 U.S. Preventive Services Task Force recommendations.
        Cancer. 2013; 119: 2518-2523https://doi.org/10.1002/cncr.28105
        • Radhakrishnan A
        • Nowak SA
        • Parker AM
        • Visvanathan K
        • Pollack CE.
        Physician breast cancer screening recommendations following guideline changes: results of a national survey.
        JAMA Intern Med. 2017; 177: 877-878https://doi.org/10.1001/jamainternmed.2017.0453
        • Haas JS
        • Sprague BL
        • Klabunde CN
        • et al.
        Provider attitudes and screening practices following changes in breast and cervical cancer screening guidelines.
        J Gen Intern Med. 2016; 31: 52-59https://doi.org/10.1007/s11606-015-3449-5
        • Patel NS
        • Lee M
        • Marti JL.
        Assessment of screening mammography recommendations by breast cancer centers in the U.S.
        JAMA Intern Med. 2021; 181: 717-719https://doi.org/10.1001/jamainternmed.2021.0157
        • Allen SV
        • Solberg Nes L
        • Marnach ML
        • et al.
        Patient understanding of the revised USPSTF screening mammogram guidelines: need for development of patient decision aids.
        BMC Womens Health. 2012; 12: 36https://doi.org/10.1186/1472-6874-12-36
        • Allen JD
        • Bluethmann SM
        • Sheets M
        • et al.
        Women's responses to changes in U.S. Preventive Task Force's mammography screening guidelines: results of focus groups with ethnically diverse women.
        BMC Public Health. 2013; 13: 1169https://doi.org/10.1186/1471-2458-13-1169
        • Hoffmann TC
        • Del Mar C.
        Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review.
        JAMA Intern Med. 2015; 175: 274-286https://doi.org/10.1001/jamainternmed.2014.6016
        • Schousboe JT
        • Kerlikowske K
        • Loh A
        • Cummings SR.
        Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
        Ann Intern Med. 2011; 155: 10-20https://doi.org/10.7326/0003-4819-155-1-201107050-00003
        • Shieh Y
        • Eklund M
        • Madlensky L
        • et al.
        Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial.
        J Natl Cancer Inst. 2017; 109https://doi.org/10.1093/jnci/djw290
        • Vilaprinyo E
        • Forné C
        • Carles M
        • et al.
        Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
        PLoS One. 2014; 9: e86858https://doi.org/10.1371/journal.pone.0086858
        • Costantino JP
        • Gail MH
        • Pee D
        • et al.
        Validation studies for models projecting the risk of invasive and total breast cancer incidence.
        J Natl Cancer Inst. 1999; 91: 1541-1548https://doi.org/10.1093/jnci/91.18.1541
        • Tice JA
        • Bissell MCS
        • Miglioretti DL
        • et al.
        Validation of the breast cancer surveillance consortium model of breast cancer risk.
        Breast Cancer Res Treat. 2019; 175: 519-523https://doi.org/10.1007/s10549-019-05167-2
        • Sabatino SA
        • McCarthy EP
        • Phillips RS
        • Burns RB.
        Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers.
        Cancer Detect Prev. 2007; 31: 375-383https://doi.org/10.1016/j.cdp.2007.08.003
        • McGuinness JE
        • Ueng W
        • Trivedi MS
        • et al.
        Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women.
        Cancer Epidemiol Biomarkers Prev. 2018; 27: 446-453https://doi.org/10.1158/1055-9965.EPI-17-0009
        • Kaplan CP
        • Haas JS
        • Pérez-Stable EJ
        • Des Jarlais G
        • Gregorich SE.
        Factors affecting breast cancer risk reduction practices among California physicians.
        Prev Med. 2005; 41: 7-15https://doi.org/10.1016/j.ypmed.2004.09.041
        • Jiang X
        • McGuinness JE
        • Sin M
        • Silverman T
        • Kukafka R
        • Crew KD.
        Identifying women at high risk for breast cancer using data from the electronic health record compared with self-report.
        JCO Clin Cancer Inform. 2019; 3: 1-8https://doi.org/10.1200/CCI.18.00072
        • Sin M
        • McGuinness JE
        • Trivedi MS
        • et al.
        Automatic genetic risk assessment calculation using breast cancer family history data from the EHR compared to self-report.
        AMIA Annu Symp Proc. 2018; 2018: 970-978
        • Hartmann LC
        • Sellers TA
        • Frost MH
        • et al.
        Benign breast disease and the risk of breast cancer.
        N Engl J Med. 2005; 353: 229-237https://doi.org/10.1056/NEJMoa044383
        • D’Orsi CJ
        • ACR
        2013 ACR BI-RADS Atlas: Breast Imaging Reporting And Data System.
        American College of Radiology, 2014 (Accessed September 12, 2022)
        • Nelson HD
        • Fu R
        • Griffin JC
        • Nygren P
        • Smith MEB
        • Humphrey L.
        Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
        Ann Intern Med. 2009; 151: 703-715https://doi.org/10.7326/0003-4819-151-10-200911170-00147
        • Nelson HD
        • O'Meara ES
        • Kerlikowske K
        • Balch S
        • Miglioretti D
        Factors associated with rates of false-positive and false-negative results from digital mammography screening: an analysis of registry data.
        Ann Intern Med. 2016; 164: 226-235https://doi.org/10.7326/M15-0971
        • Kerlikowske K
        • Zhu W
        • Hubbard RA
        • et al.
        Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
        JAMA Intern Med. 2013; 173: 807-816https://doi.org/10.1001/jamainternmed.2013.307
        • Bolejko A
        • Hagell P
        • Wann-Hansson C
        • Prevalence Zackrisson S.
        long-term development, and predictors of psychosocial consequences of false-positive mammography among women attending population-based screening.
        Cancer Epidemiol Biomarkers Prev. 2015; 24: 1388-1397https://doi.org/10.1158/1055-9965.EPI-15-0060
        • Brodersen J
        • Siersma VD.
        Long-term psychosocial consequences of false-positive screening mammography.
        Ann Fam Med. 2013; 11: 106-115https://doi.org/10.1370/afm.1466
        • McGuinness JE
        • Zhang TM
        • Cooper K
        • et al.
        Extraction of electronic health record data using fast healthcare interoperability resources for automated breast cancer risk assessment.
        AMIA Annu Symp Proc. 2021; 2021: 843-852
      4. Li Y, Carlson E, Hernández DA, et al. Patient perception and cost-effectiveness of a patient navigation program to improve breast cancer screening for Hispanic women. Health Equity. 2019;3(1):280–286. https://doi.org/10.1089/heq.2018.0089.

        • Luque JS
        • Logan A
        • Soulen G
        • et al.
        Systematic review of mammography screening educational interventions for Hispanic women in the United States.
        J Cancer Educ. 2019; 34: 412-422https://doi.org/10.1007/s13187-018-1321-0
        • Shoemaker ML
        • White MC.
        Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the National Health Interview survey 2008, 2010, and 2013.
        Cancer Causes Control. 2016; 27: 453-457https://doi.org/10.1007/s10552-016-0718-5
        • Ahmed AT
        • Welch BT
        • Brinjikji W
        • et al.
        Racial disparities in screening mammography in the United States: a systematic review and meta-analysis.
        J Am Coll Radiol. 2017; 14: 157-165.e9https://doi.org/10.1016/j.jacr.2016.07.034
        • White A
        • Thompson TD
        • White MC
        • et al.
        Cancer screening test use - United States, 2015.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 201-206https://doi.org/10.15585/mmwr.mm6608a1
        • Stiel L
        • Soret S
        • Montgomery S.
        Geographic patterns of change over time in mammography: differences between black and white U.S. Medicare enrollees.
        Cancer Epidemiol. 2017; 46: 57-65https://doi.org/10.1016/j.canep.2016.11.008
        • Mobley LR
        • Subramanian S
        • Tangka FK
        • et al.
        Breast cancer screening among women with Medicaid, 2006–2008: a multilevel analysis.
        J Racial Ethn Health Disparities. 2017; 4: 446-454https://doi.org/10.1007/s40615-016-0245-9
        • Toyoda Y
        • Jeong Oh EJ
        • Premaratne ID
        • Chiuzan C
        • Rohde CH
        Affordable Care Act state-specific Medicaid expansion: impact on health insurance coverage and breast cancer screening rate.
        J Am Coll Surg. 2020; 230: 775-783https://doi.org/10.1016/j.jamcollsurg.2020.01.031
        • Kim U
        • Koroukian S
        • Statler A
        • Rose J.
        The effect of Medicaid expansion among adults from low-income communities on stage at diagnosis in those with screening-amenable cancers.
        Cancer. 2020; 126: 4209-4219https://doi.org/10.1002/cncr.32895
        • Le Blanc JM
        • Heller DR
        • Friedrich A
        • Lannin DR
        • Park TS
        Association of Medicaid expansion under the Affordable Care Act with breast cancer stage at diagnosis.
        JAMA Surg. 2020; 155: 752-758https://doi.org/10.1001/jamasurg.2020.1495
        • Goldman LE
        • Walker R
        • Miglioretti DL
        • Smith-Bindman R
        • Kerlikowske K
        • National Cancer Institute Breast Cancer Surveillance Consortium
        Accuracy of diagnostic mammography at facilities serving vulnerable women.
        Med Care. 2011; 49: 67-75https://doi.org/10.1097/MLR.0b013e3181f380e0
        • Jafri NF
        • Ayyala RS
        • Ozonoff A
        • Jordan-Gray J
        • Slanetz PJ.
        Screening mammography: does ethnicity influence patient preferences for higher recall rates given the potential for earlier detection of breast cancer?.
        Radiology. 2008; 249: 785-791https://doi.org/10.1148/radiol.2493072176